|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Safety and immu- nogenicity of a meningococcal B bivalent rLP2086 vaccine in healthy toddlers aged 18-36 months: a phase 1 randomized-con- trolled clinical trial显示文摘 | Marshall HS Richmond PC Nissen MD | 2012 | Pediatr Infect Dis J2012，31，10： | 1 |
| 2 | Safety and immuno- genicity of a prototype adjuvanted inactivated split-virus influenza A(H5N1 ) vaccine in infants and children 显示文摘 | Nolan T Richmond PC Formica NT | 2008 | Vaccine2008，26，50： | 1 |
| 3 | Safety and immunogenielty of a meningoeoeeal B bivalent rLP2086 vac- cine in healthy toddlers aged 18-36 months, a phase 1 ran- domized-controlled clinical trial 显示文摘 | Marshall HS Richmond PC Nissen MD | 2012 | Pediatr Infect Dis J2012，31，： | 1 |
| 4 | Safety and im- munogenicity of a meningococcal B bivalent rLP2086 vaccine in healthy toddlers aged 18-36 months: a phase 1 randomized-con- trolled clinical trial 显示文摘 | Marshall HS Richmond PC Nissen MD | 2012 | Pediatr Infect Dis J2012，31，10： | 1 |
| 5 | A bivalent Neisseria meningitidis recombinant lipidated factor H binding protein vaccine in young adults:results of a randomised,controlled,dose-escalation phase Ⅰ trial显示文摘 | Richmond PC Nissen MD Marshall HS | 2012 | Vaccine2012，30，43： | 1 |
| 6 | Safety and immunogenicity of a meningococcal B bivalent rLP2086 vaccine in healthy toddlers aged 18-36 months:a phase Ⅰ randomizedcontrolled clinical trial显示文摘 | Marshall HS Richmond PC Nissen MD | 2012 | Pediatr Infect Dis J2012，31，10： | 1 |
| 7 | Induction of immunolog-ical memory in UK infants by a meningococcal A/C conjugate vaccine显示文摘 | Borrow R Fox AJ Richmond PC | | 0，，03： | 1 |
| 8 | Safety,immunogenicity,and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents:a randomised,single-blind,placebo-controlled,phase 2 trial显示文摘 | Richmond PC Marshall HS Nissen MD | 2012 | Lancet Infect Dis2012，12，8： | 1 |
| 9 | A phase 2 openlabel safety and immunogenicity study of a meningococcal B bivalent rLP2086 vaccine in healthy adults显示文摘 | Marshall HS Richmond PC Nissen MD | 2013 | Vaccine2013，31，12： | 1 |
| 10 | Machiavellian tendencies of nonprofit health care employees显示文摘 | Richmond KA Smith PC | | 0，，02： | 1 |
| 11 | Maternal antibodies to pneumolysin but not to pneumococcal surface protein A delay early pneumococcal carriage in high-risk papua new guinean infants显示文摘 | Francis JP Richmond PC Pomat WS | 2009 | Clin Vaccine Immunol2009，16，11： | 1 |
| 12 | Safety and irrgramogenicity of a meningococcal B bivalent rLg2086 vaccine in healthy toddlers aged 18-36 months: a phase 1 randomized-controlled clinical trial 显示文摘 | Marshall HS Richmond PC Nissen MD | 2012 | Pediatr Infect Disease J2012，31，10： | 1 |
| 13 | Safety, immunogenicity, and tohrability of mertingococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: a randomised, single-blind, placebo-controlled, phase 2 tfial显示文摘 | Richmond PC Marshall HS Nissen MD | 2012 | Lancet Infect Dis2012，12，8： | 1 |
| 14 | A phase 2 open-label safety and immunogenieity study of a meningococeal B bivalent rLP2086 vaccine in healthy adults 显示文摘 | Marshal HS Richmond PC Nissen MD | 2013 | Vaccine2013，31，12： | 1 |
| 15 | Safety and im- munogenieity of a prototype adjuvanted inactivated split - virus influenza A (H5N1) vaccine in infants and children 显示文摘 | NOLAN T RICHMOND PC FORMICA NT | 2008 | Vac- eine2008，26，50： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员